TARO PHARMACEUTICAL INDS LTD's ticker is TARO and the CUSIP is M8737E108. A total of 126 filers reported holding TARO PHARMACEUTICAL INDS LTD in Q4 2017. The put-call ratio across all filers is 9.32 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2019 | $249,000 | -5.3% | 3,306 | +7.2% | 0.00% | -33.3% |
| Q2 2019 | $263,000 | -5.1% | 3,084 | +20.3% | 0.00% | 0.0% |
| Q1 2019 | $277,000 | -89.8% | 2,563 | -90.1% | 0.00% | -93.6% |
| Q4 2017 | $2,712,000 | +579.7% | 25,898 | +627.5% | 0.05% | +487.5% |
| Q2 2017 | $399,000 | +85.6% | 3,560 | +137.3% | 0.01% | -52.9% |
| Q1 2016 | $215,000 | – | 1,500 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| HealthInvest Partners AB | 78,905 | $8,306,000 | 7.65% |
| FORT, L.P. | 157,584 | $16,589,000 | 4.68% |
| MATTHEWS INTERNATIONAL CAPITAL MANAGEMENT LLC | 808,200 | $85,079,000 | 4.39% |
| Strategic Global Advisors, LLC | 81,432 | $8,572,000 | 3.18% |
| Prince Street Capital Management LLC | 48,700 | $5,127,000 | 1.62% |
| Analyst IMS Investment Management Services Ltd. | 31,438 | $3,309,000 | 1.45% |
| Freestone Capital Holdings, LLC | 84,900 | $8,937,000 | 0.77% |
| RPG Investment Advisory, LLC | 17,227 | $1,813,000 | 0.61% |
| CLINTON GROUP INC | 46,370 | $4,881,000 | 0.28% |
| USA FINANCIAL FORMULAS | 10,786 | $1,135,000 | 0.28% |